Cover Image

Indirect effect and pneumococcal conjugate vaccines (Original version in English)

Show other versions (1)

Saved in:

Bibliographic Details
Main Author:	L. Temimi (Author)
Format:	Book
Published:	Union of pediatricians of Russia, 2009-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Indirect effect and pneumococcal conjugate vaccines (Original version in English)
by: L. Temimi
Published: (2009)

Indirect effect and pneumococcal conjugate vaccines
by: L. Temimi
Published: (2009)

Indirect effect and pneumococcal conjugate vaccines
by: L. Temimi
Published: (2009)

Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis
by: Tinevimbo Shiri, DrPhD, et al.
Published: (2017)

Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation
by: Ron Dagan
Published: (2019)

Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey
by: J. P. Sevilla, et al.
Published: (2020)

Direct and indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with pneumonia from formal and informal settlements in Mongolia: an observational study
by: Jocelyn Chan, et al.
Published: (2021)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012)

Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan
by: Shigeki Nakamura, et al.
Published: (2024)

Determining the pneumococcal conjugate vaccine coverage required for indirect protection within Asia and the Pacific: a prospective observational study
by: Jocelyn Chan, MBBS, et al.
Published: (2019)

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
by: Hyunju Lee, et al.
Published: (2014)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
by: N. L. Chernaya, et al.
Published: (2013)

CONJUGATED PNEUMOCOCCAL VACCINE FOR IMMUNIZATION OF CHILDREN - WHO RECOMMENDATIONS
by: L.S. Namazova
Published: (2007)

CONJUGATED PNEUMOCOCCAL VACCINE FOR IMMUNIZATION OF CHILDREN - WHO RECOMMENDATIONS
by: L.S. Namazova
Published: (2007)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
by: James T. Peterson, et al.
Published: (2019)

13-valent pneumococcal conjugate vaccine in Africa
by: Robert Cohen, et al.
Published: (2017)

Conjugate pneumococcal vaccines: Need and choice in India
by: Akash Malik, et al.
Published: (2013)

Herd protection induced by pneumococcal conjugate vaccine
by: Keith P Klugman
Published: (2014)

Incidence of pneumonia is not reduced by pneumococcal conjugate vaccine
by: Sona Chowdhary, et al.
Published: (2008)

Pneumococcal conjugate vaccine is efficacious and effective in reducing the burden of pneumonia
by: Shabir A Madhi, et al.
Published: (2008)

CLINICAL AND IMMUNOLOGICAL EFFECT OF PNEUMOCOCCAL CONJUGATED VACCINES IN IMMUNOCOMPROMISED PATIENTS
by: A.A. Tarasova, et al.
Published: (2010)

CLINICAL AND IMMUNOLOGICAL EFFECT OF PNEUMOCOCCAL CONJUGATED VACCINES IN IMMUNOCOMPROMISED PATIENTS
by: A.A. Tarasova, et al.
Published: (2010)

Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
by: Hye-Young Kim, et al.
Published: (2021)

Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness
by: Lee M Hampton, et al.
Published: (2012)

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
by: George Gourzoulidis, et al.
Published: (2023)

Pneumococcal conjugate 7-valent vacciPNEUMOCOCCAL CONJUGATE 7-VALENT VACCINE IN CHILDREN. REGIONAL EXPERIENCEne in children. Regional experience
by: N. L. Chernaya, et al.
Published: (2012)

Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine
by: Matt Wasserman, et al.
Published: (2018)

Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
by: Johnna Perdrizet, et al.
Published: (2021)

INTERNATIONAL EXPERIENCE WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: David G. McIntosh
Published: (2009)

INTERNATIONAL EXPERIENCE WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: David G. McIntosh
Published: (2009)

Meeting the challenge: prevention of pneumococcal disease with conjugate vaccines
by: Echániz-Avilés Irma Gabriela, et al.
Published: (2001)

Pneumococcal conjugate vaccines: choice of schedule and product development
by: Jin Lee
Published: (2020)

Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age
by: Raul E. Isturiz, et al.
Published: (2018)

Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus "no vaccination" and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine
by: Miguel Gouveia, et al.
Published: (2019)

Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
by: Cornelis H. van Werkhoven
Published: (2017)

Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis
by: Cynthia Chen, PhD, et al.
Published: (2019)

Burden of pneumococcal disease in children in Cuba before the introduction of a novel pneumococcal conjugate vaccine
by: Nivaldo Linares-Pérez, et al.
Published: (2019)

Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015)

PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children
by: Timothy J Chapman, et al.
Published: (2024)